Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
R&D
Agency Leadership
Compliance
Complete Response Letters
Drug Review Profiles
Scrip
Nine More Companies Take Trump’s MFN Drug Pricing Deal, Lower Prices For Tariff Relief
Dec 20 2025
•
By
Mandy Jackson
BMS will make anticoagulant Eliquis free for Medicaid, a single-digit percentage of its sales for the product.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pricing Debate
More from United States